This article is part of the supplement: The Framingham Heart Study 100,000 single nucleotide polymorphisms resource
Framingham Heart Study genome-wide association: results for pulmonary function measures
-
* Corresponding author: Jemma B Wilk jwilk@bu.edu
BMC Medical Genetics 2007, 8(Suppl 1):S8 doi:10.1186/1471-2350-8-S1-S8
Accesses
- Last 30 days: 27 accesses
- Last year: 485 accesses
- All time: 3385 accesses
Cited by
BioMed Central: 4 citations
|
Chronic obstructive pulmonary disease: towards pharmacogenetics Alice M Wood, See Ling Tan, Robert A Stockley Genome Medicine 2009, 1:112 (30 November 2009) Knowledge of the pathophysiology and genetic risk factors for chronic obstructive pulmonary disease may help identify individuals who will respond differently to treatments.
|
|
IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study Dilyara G Yanbaeva, Mieke A Dentener, Martijn A Spruit, Jeanine J Houwing-Duistermaat, Daniel Kotz, Valéria Passos, Emiel FM Wouters BMC Medical Genetics 2009, 10:23 (9 March 2009) |
|
Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity Terttu Harju, Witold Mazur, Heta Merikallio, Ylermi Soini, Vuokko L Kinnula Respiratory Research 2008, 9:80 (13 December 2008) |
|
L Adrienne Cupples, Heather T Arruda, Emelia J Benjamin, Ralph B D'Agostino, Serkalem Demissie, Anita L DeStefano, Josée Dupuis, Kathleen M Falls, Caroline S Fox, Daniel J Gottlieb, Diddahally R Govindaraju, Chao-Yu Guo, Nancy L Heard-Costa, Shih-Jen Hwang, Sekar Kathiresan, Douglas P Kiel, Jason M Laramie, Martin G Larson, Daniel Levy, Chun-Yu Liu, Kathryn L Lunetta, Matthew D Mailman, Alisa K Manning, James B Meigs, Joanne M Murabito, Christopher Newton-Cheh, George T O'Connor, Christopher J O'Donnell, Mona Pandey, Sudha Seshadri et al. BMC Medical Genetics 2007, 8(Suppl 1):S1 (19 September 2007) |